首页> 外文期刊>Stem Cell Research & Therapy >Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming
【24h】

Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming

机译:牙髓干细胞的适宜表观遗传特性是无异源游离基因重编程的高能力

获取原文
获取外文期刊封面目录资料

摘要

While a shift towards non-viral and animal component-free methods of generating induced pluripotent stem (iPS) cells is preferred for safer clinical applications, there is still a shortage of reliable cell sources and protocols for efficient reprogramming. Here, we show a robust episomal and xeno-free reprogramming strategy for human iPS generation from dental pulp stem cells (DPSCs) which renders good efficiency (0.19%) over a short time frame (13–18 days). The robustness of DPSCs as starting cells for iPS induction is found due to their exceptional inherent stemness properties, developmental origin from neural crest cells, specification for tissue commitment, and differentiation capability. To investigate the epigenetic basis for the high reprogramming efficiency of DPSCs, we performed genome-wide DNA methylation analysis and found that the epigenetic signature of DPSCs associated with pluripotent, developmental, and ecto-mesenchymal genes is relatively close to that of iPS and embryonic stem (ES) cells. Among these genes, it is found that overexpression of PAX9 and knockdown of HERV-FRD improved the efficiencies of iPS generation. In conclusion, our study provides underlying epigenetic mechanisms that establish a robust platform for efficient generation of iPS cells from DPSCs, facilitating industrial and clinical use of iPS technology for therapeutic needs.
机译:尽管为了更安全的临床应用,人们倾向于使用非病毒和无动物成分的方法来生成诱导多能干(iPS)细胞,但仍然缺少可靠的细胞来源和有效的重新编程方案。在这里,我们显示了从牙髓干细胞(DPSC)生成人iPS的强大的游离和无异种重编程策略,可在短时间内(13-18天)提供良好的效率(0.19%)。 DPSC作为iPS诱导起始细胞的稳健性归因于其出色的固有干特性,神经rest细胞的发育起源,组织定性和分化能力。为了研究DPSCs高重编程效率的表观遗传基础,我们进行了全基因组DNA甲基化分析,发现与多能,发育和外间充质基因相关的DPSC的表观遗传学特征相对接近于iPS和胚胎干的表观遗传学特征。 (ES)单元。在这些基因中,发现PAX9的过度表达和HERV-FRD的敲低提高了iPS产生的效率。总之,我们的研究提供了潜在的表观遗传机制,这些机制为从DPSC有效生成iPS细胞建立了一个强大的平台,从而促进了iPS技术在工业和临床上的治疗需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号